NCT01557452 - Open-Label Extension of the Dose Finding Study (DSC/08/2357/36) in Patients With Poly Juvenile Idiopathic Arthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 28, 2011

Primary Completion Date

January 27, 2014

Study Completion Date

January 27, 2014

Conditions

Juvenile Idiopathic Arthritis

Interventions

DRUG

Givinostat

ready-to-use oral suspension, administered in fed condition and on a outpatient basis, especially intended for paediatric patients

Trial Locations (1)

1st Faculty of Medicine and General Faculty Hospital, Prague